Interleukin 1 (IL1) Market Report

Global and Region Interleukin 1 (IL1) Market Demand & Opportunity Outlook 2022-2028

  • POSTDATE：Jul 30, 2022
  • PAGES：210
  • REPORT CODE：GMM900273
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • The report details the trend, potential and market size of Interleukin 1 (IL1) market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Interleukin 1 (IL1)market, defines the market attractiveness level of Interleukin 1 (IL1) market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Interleukin 1 (IL1) industry, describes the types of Interleukin 1 (IL1) market, the applications of major players and the market size, and deeply analyzes the current situation of the global Interleukin 1 (IL1) market and the development prospects and opportunities of Interleukin 1 (IL1) industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Interleukin 1 (IL1) market in Chapter 13.

    By Player:

    • Immune Response BioPharma Inc

    • Swedish Orphan Biovitrum AB

    • Apexigen Inc

    • AbbVie Inc

    • Orphit SAS

    • Anacor Pharmaceuticals Inc

    • Exicure Inc

    • Opsona Therapeutics Ltd

    • Optimum Therapeutics LLC

    • R Pharm

    • TWi Biotechnology Inc

    • Regeneron Pharmaceuticals Inc

    • XBiotech Inc

    • Peptinov SAS

    • Cell Medica Ltd

    • Omnitura Therapeutics Inc

    • Novartis AG

    By Type:

    • APX-002

    • Canakinumab

    • Diacerein CR

    • IR-1000

    • Others

    By End-User:

    • Esophageal Cancer

    • Fallopian Tube Cancer

    • Bladder Cancer

    • Bechcer Disease

    • Others

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Interleukin 1 (IL1) Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Interleukin 1 (IL1) Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Interleukin 1 (IL1) Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Interleukin 1 (IL1) Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Interleukin 1 (IL1) Market Analysis and Outlook to 2022

    • 7.1 Global Interleukin 1 (IL1) Consumption (2017-2022)

    • 7.2 United States Interleukin 1 (IL1) Consumption (2017-2022)

    • 7.3 Europe Interleukin 1 (IL1) Consumption (2017-2022)

    • 7.4 China Interleukin 1 (IL1) Consumption (2017-2022)

    • 7.5 Japan Interleukin 1 (IL1) Consumption (2017-2022)

    • 7.6 India Interleukin 1 (IL1) Consumption (2017-2022)

    • 7.7 South Korea Interleukin 1 (IL1) Consumption (2017-2022)

    8 Region and Country-wise Interleukin 1 (IL1) Market Analysis and Outlook to 2028

    • 8.1 Global Interleukin 1 (IL1) Consumption Forecast (2022-2028)

    • 8.2 United States Interleukin 1 (IL1) Consumption Forecast (2022-2028)

    • 8.3 Europe Interleukin 1 (IL1) Consumption Forecast (2022-2028)

    • 8.4 China Interleukin 1 (IL1) Consumption Forecast (2022-2028)

    • 8.5 Japan Interleukin 1 (IL1) Consumption Forecast (2022-2028)

    • 8.6 India Interleukin 1 (IL1) Consumption Forecast (2022-2028)

    • 8.7 South Korea Interleukin 1 (IL1) Consumption Forecast (2022-2028)

    9 Global Interleukin 1 (IL1) Market Outlook by Types and Applications to 2022

    • 9.1 Global Interleukin 1 (IL1) Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global APX-002 Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Canakinumab Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global Diacerein CR Consumption and Growth Rate (2017-2022)

      • 9.1.4 Global IR-1000 Consumption and Growth Rate (2017-2022)

      • 9.1.5 Global Others Consumption and Growth Rate (2017-2022)

    • 9.2 Global Interleukin 1 (IL1) Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Esophageal Cancer Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Fallopian Tube Cancer Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Bladder Cancer Consumption and Growth Rate (2017-2022)

      • 9.2.4 Global Bechcer Disease Consumption and Growth Rate (2017-2022)

      • 9.2.5 Global Others Consumption and Growth Rate (2017-2022)

    10 Global Interleukin 1 (IL1) Market Outlook by Types and Applications to 2028

    • 10.1 Global Interleukin 1 (IL1) Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global APX-002 Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global Canakinumab Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.3 Global Diacerein CR Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.4 Global IR-1000 Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.5 Global Others Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Interleukin 1 (IL1) Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Esophageal Cancer Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Fallopian Tube Cancer Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.3 Global Bladder Cancer Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.4 Global Bechcer Disease Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.5 Global Others Consumption Forecast and Growth Rate (2022-2028)

    11 Global Interleukin 1 (IL1) Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Interleukin 1 (IL1) Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Interleukin 1 (IL1) Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Interleukin 1 (IL1) Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Interleukin 1 (IL1) Market Competitive Analysis

    • 14.1 Immune Response BioPharma Inc

      • 14.1.1 Immune Response BioPharma Inc Company Details

      • 14.1.2 Immune Response BioPharma Inc Interleukin 1 (IL1) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 Immune Response BioPharma Inc Interleukin 1 (IL1) Product and Service

    • 14.2 Swedish Orphan Biovitrum AB

      • 14.2.1 Swedish Orphan Biovitrum AB Company Details

      • 14.2.2 Swedish Orphan Biovitrum AB Interleukin 1 (IL1) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 Swedish Orphan Biovitrum AB Interleukin 1 (IL1) Product and Service

    • 14.3 Apexigen Inc

      • 14.3.1 Apexigen Inc Company Details

      • 14.3.2 Apexigen Inc Interleukin 1 (IL1) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 Apexigen Inc Interleukin 1 (IL1) Product and Service

    • 14.4 AbbVie Inc

      • 14.4.1 AbbVie Inc Company Details

      • 14.4.2 AbbVie Inc Interleukin 1 (IL1) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 AbbVie Inc Interleukin 1 (IL1) Product and Service

    • 14.5 Orphit SAS

      • 14.5.1 Orphit SAS Company Details

      • 14.5.2 Orphit SAS Interleukin 1 (IL1) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 Orphit SAS Interleukin 1 (IL1) Product and Service

    • 14.6 Anacor Pharmaceuticals Inc

      • 14.6.1 Anacor Pharmaceuticals Inc Company Details

      • 14.6.2 Anacor Pharmaceuticals Inc Interleukin 1 (IL1) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 Anacor Pharmaceuticals Inc Interleukin 1 (IL1) Product and Service

    • 14.7 Exicure Inc

      • 14.7.1 Exicure Inc Company Details

      • 14.7.2 Exicure Inc Interleukin 1 (IL1) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.7.3 Exicure Inc Interleukin 1 (IL1) Product and Service

    • 14.8 Opsona Therapeutics Ltd

      • 14.8.1 Opsona Therapeutics Ltd Company Details

      • 14.8.2 Opsona Therapeutics Ltd Interleukin 1 (IL1) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.8.3 Opsona Therapeutics Ltd Interleukin 1 (IL1) Product and Service

    • 14.9 Optimum Therapeutics LLC

      • 14.9.1 Optimum Therapeutics LLC Company Details

      • 14.9.2 Optimum Therapeutics LLC Interleukin 1 (IL1) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.9.3 Optimum Therapeutics LLC Interleukin 1 (IL1) Product and Service

    • 14.10 R Pharm

      • 14.10.1 R Pharm Company Details

      • 14.10.2 R Pharm Interleukin 1 (IL1) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.10.3 R Pharm Interleukin 1 (IL1) Product and Service

    • 14.11 TWi Biotechnology Inc

      • 14.11.1 TWi Biotechnology Inc Company Details

      • 14.11.2 TWi Biotechnology Inc Interleukin 1 (IL1) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.11.3 TWi Biotechnology Inc Interleukin 1 (IL1) Product and Service

    • 14.12 Regeneron Pharmaceuticals Inc

      • 14.12.1 Regeneron Pharmaceuticals Inc Company Details

      • 14.12.2 Regeneron Pharmaceuticals Inc Interleukin 1 (IL1) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.12.3 Regeneron Pharmaceuticals Inc Interleukin 1 (IL1) Product and Service

    • 14.13 XBiotech Inc

      • 14.13.1 XBiotech Inc Company Details

      • 14.13.2 XBiotech Inc Interleukin 1 (IL1) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.13.3 XBiotech Inc Interleukin 1 (IL1) Product and Service

    • 14.14 Peptinov SAS

      • 14.14.1 Peptinov SAS Company Details

      • 14.14.2 Peptinov SAS Interleukin 1 (IL1) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.14.3 Peptinov SAS Interleukin 1 (IL1) Product and Service

    • 14.15 Cell Medica Ltd

      • 14.15.1 Cell Medica Ltd Company Details

      • 14.15.2 Cell Medica Ltd Interleukin 1 (IL1) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.15.3 Cell Medica Ltd Interleukin 1 (IL1) Product and Service

    • 14.16 Omnitura Therapeutics Inc

      • 14.16.1 Omnitura Therapeutics Inc Company Details

      • 14.16.2 Omnitura Therapeutics Inc Interleukin 1 (IL1) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.16.3 Omnitura Therapeutics Inc Interleukin 1 (IL1) Product and Service

    • 14.17 Novartis AG

      • 14.17.1 Novartis AG Company Details

      • 14.17.2 Novartis AG Interleukin 1 (IL1) Sales, Price, Value and Gross Profit (2017-2022)

      • 14.17.3 Novartis AG Interleukin 1 (IL1) Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Interleukin 1 (IL1)

    • Figure Interleukin 1 (IL1) Picture

    • Table Global Interleukin 1 (IL1) Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Interleukin 1 (IL1) Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Interleukin 1 (IL1) Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Interleukin 1 (IL1) Consumption by Country (2017-2022)

    • Figure United States Interleukin 1 (IL1) Consumption and Growth Rate (2017-2022)

    • Table Europe Interleukin 1 (IL1) Consumption and Growth Rate (2017-2022)

    • Figure China Interleukin 1 (IL1) Consumption and Growth Rate (2017-2022)

    • Figure Japan Interleukin 1 (IL1) Consumption and Growth Rate (2017-2022)

    • Figure India Interleukin 1 (IL1) Consumption and Growth Rate (2017-2022)

    • Figure South Korea Interleukin 1 (IL1) Consumption and Growth Rate (2017-2022)

    • Figure Global Interleukin 1 (IL1) Consumption Forecast by Country (2022-2028)

    • Figure United States Interleukin 1 (IL1) Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Interleukin 1 (IL1) Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Interleukin 1 (IL1) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Interleukin 1 (IL1) Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Interleukin 1 (IL1) Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Interleukin 1 (IL1) Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global APX-002 Consumption and Growth Rate (2017-2022)

    • Figure Global Canakinumab Consumption and Growth Rate (2017-2022)

    • Figure Global Diacerein CR Consumption and Growth Rate (2017-2022)

    • Figure Global IR-1000 Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global Esophageal Cancer Consumption and Growth Rate (2017-2022)

    • Figure Global Fallopian Tube Cancer Consumption and Growth Rate (2017-2022)

    • Figure Global Bladder Cancer Consumption and Growth Rate (2017-2022)

    • Figure Global Bechcer Disease Consumption and Growth Rate (2017-2022)

    • Figure Global Others Consumption and Growth Rate (2017-2022)

    • Figure Global APX-002 Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Canakinumab Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Diacerein CR Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global IR-1000 Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Esophageal Cancer Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Fallopian Tube Cancer Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Bladder Cancer Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Bechcer Disease Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Others Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Interleukin 1 (IL1) Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Interleukin 1 (IL1) Export by Region (Top 5 Countries) (2017-2028)

    • Table Immune Response BioPharma Inc (Foundation Year, Company Profile and etc.)

    • Table Immune Response BioPharma Inc Interleukin 1 (IL1) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Immune Response BioPharma Inc Interleukin 1 (IL1) Product and Service

    • Table Swedish Orphan Biovitrum AB (Foundation Year, Company Profile and etc.)

    • Table Swedish Orphan Biovitrum AB Interleukin 1 (IL1) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Swedish Orphan Biovitrum AB Interleukin 1 (IL1) Product and Service

    • Table Apexigen Inc (Foundation Year, Company Profile and etc.)

    • Table Apexigen Inc Interleukin 1 (IL1) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Apexigen Inc Interleukin 1 (IL1) Product and Service

    • Table AbbVie Inc (Foundation Year, Company Profile and etc.)

    • Table AbbVie Inc Interleukin 1 (IL1) Sales, Price, Value and Gross Profit (2017-2022)

    • Table AbbVie Inc Interleukin 1 (IL1) Product and Service

    • Table Orphit SAS (Foundation Year, Company Profile and etc.)

    • Table Orphit SAS Interleukin 1 (IL1) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Orphit SAS Interleukin 1 (IL1) Product and Service

    • Table Anacor Pharmaceuticals Inc (Foundation Year, Company Profile and etc.)

    • Table Anacor Pharmaceuticals Inc Interleukin 1 (IL1) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Anacor Pharmaceuticals Inc Interleukin 1 (IL1) Product and Service

    • Table Exicure Inc (Foundation Year, Company Profile and etc.)

    • Table Exicure Inc Interleukin 1 (IL1) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Exicure Inc Interleukin 1 (IL1) Product and Service

    • Table Opsona Therapeutics Ltd (Foundation Year, Company Profile and etc.)

    • Table Opsona Therapeutics Ltd Interleukin 1 (IL1) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Opsona Therapeutics Ltd Interleukin 1 (IL1) Product and Service

    • Table Optimum Therapeutics LLC (Foundation Year, Company Profile and etc.)

    • Table Optimum Therapeutics LLC Interleukin 1 (IL1) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Optimum Therapeutics LLC Interleukin 1 (IL1) Product and Service

    • Table R Pharm (Foundation Year, Company Profile and etc.)

    • Table R Pharm Interleukin 1 (IL1) Sales, Price, Value and Gross Profit (2017-2022)

    • Table R Pharm Interleukin 1 (IL1) Product and Service

    • Table TWi Biotechnology Inc (Foundation Year, Company Profile and etc.)

    • Table TWi Biotechnology Inc Interleukin 1 (IL1) Sales, Price, Value and Gross Profit (2017-2022)

    • Table TWi Biotechnology Inc Interleukin 1 (IL1) Product and Service

    • Table Regeneron Pharmaceuticals Inc (Foundation Year, Company Profile and etc.)

    • Table Regeneron Pharmaceuticals Inc Interleukin 1 (IL1) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Regeneron Pharmaceuticals Inc Interleukin 1 (IL1) Product and Service

    • Table XBiotech Inc (Foundation Year, Company Profile and etc.)

    • Table XBiotech Inc Interleukin 1 (IL1) Sales, Price, Value and Gross Profit (2017-2022)

    • Table XBiotech Inc Interleukin 1 (IL1) Product and Service

    • Table Peptinov SAS (Foundation Year, Company Profile and etc.)

    • Table Peptinov SAS Interleukin 1 (IL1) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Peptinov SAS Interleukin 1 (IL1) Product and Service

    • Table Cell Medica Ltd (Foundation Year, Company Profile and etc.)

    • Table Cell Medica Ltd Interleukin 1 (IL1) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Cell Medica Ltd Interleukin 1 (IL1) Product and Service

    • Table Omnitura Therapeutics Inc (Foundation Year, Company Profile and etc.)

    • Table Omnitura Therapeutics Inc Interleukin 1 (IL1) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Omnitura Therapeutics Inc Interleukin 1 (IL1) Product and Service

    • Table Novartis AG (Foundation Year, Company Profile and etc.)

    • Table Novartis AG Interleukin 1 (IL1) Sales, Price, Value and Gross Profit (2017-2022)

    • Table Novartis AG Interleukin 1 (IL1) Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US